The Women’s Health Initiative, launched in 1991 across 40 centers with >161,000 participants, materially influenced practice ...
The FDA approved Moderna’s Biologics License Application (BLA) for its mRNA-based flu vaccine, mRNA-1010 (mFlusiva; Moderna), ...
Prior to receiving CAR T-cell therapy, patients undergo lymphodepletion chemotherapy, explained Kerry Rogers, MD, The James.
Disease-modifying antirheumatic drug (DMARD) and tumor necrosis factor (TNF) cycling is a real and well-documented problem in ...
Katherine Wilemon, Family Heart Foundation, described the biggest unmet need when it comes to public awareness of Lp(a) and ...
Anosheh Afghahi, MD, discusses biomarker testing, trial matching technology, and community-academic partnerships to improve ...
Referral patterns skew toward older patients with fibrotic ILDs, raising concern that subspecialty centers may only capture a “tip of the iceberg” despite rising CT-driven detection. Screening for ILD ...
Prior authorization, coverage limits, and affordability screening increasingly determine when CAR T or bispecifics are ...
Young adults with sarcoma face challenges that extend well beyond treatment, and closing gaps in research funding and specialty care could improve outcomes for this population and beyond, according to ...
Six peptides received narrow advisory support for potential 503A Bulks List inclusion, an atypical outcome given FDA staff recommendations against all seven under review. Legal compounding remains ...
Noureddin framed the emergence of dual GLP-1/glucagon receptor agonism as a significant development, placing it alongside artificial intelligence as a transformative force in medicine, noting that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results